Trial reportAmerican journal of respiratory and critical care medicine2023
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation.
Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph
Trial report in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07032987 (Optimising Analgosedation in Extracorporeal Membrane Oxygenation), which is not on this map. Cited by 37 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Optimising Analgosedation in Extracorporeal Membrane Oxygenation (ECMO) Using a Co-designed Analgosedation Protocol
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.
- Antibacterial Pharmacokinetics in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review of Population Pharmacokinetic Studies.Clinical pharmacokinetics · 2026Pooled it
- Limiting collateral damage: Nosocomial infections in patients with temporary mechanical circulatory support.JHLT open · 2026Article
- Research trends and emerging topics in antifungal therapeutic drug monitoring: a bibliometric analysis with implications for clinical pharmacy practice.International journal of clinical pharmacy · 2026Review
- Daptomycin pharmacokinetics in critically ill patients receiving extracorporeal membrane oxygenation: A pilot cohort study.Journal of intensive medicine · 2026Article
- A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock.The Journal of antimicrobial chemotherapy · 2026Article
- Time-varying voriconazole clearance during extracorporeal membrane oxygenation.Antimicrobial agents and chemotherapy · 2026Observational
- Impact of extracorporeal membrane oxygenation on antimicrobial exposure in critically ill patients: a prospective observational study.Critical care (London, England) · 2026Observational
- Invasive Fungal Infections During Extracorporeal Membrane Oxygenation: A Case Series from Intensive Care Unit and Literature Review.Diagnostics (Basel, Switzerland) · 2026Article
- Antimicrobial pharmacokinetics and stewardship in critically Ill adult patients receiving ECMO: Challenges, evidence, and future directions.JHLT open · 2026Article
- Liposomal amphotericin B and renal safety: review of the evidence and clinical considerations.The Journal of antimicrobial chemotherapy · 2026Review
- Can Model-Informed Precision Dosing of Beta-Lactams in Critical Care Improve Clinical Outcomes?Chemotherapy · 2026Review
- Therapeutic drug monitoring of daptomycin in a critically ill patient cohort.Frontiers in medicine · 2026Article
- Pharmacokinetic Changes of Ceftazidime-Avibactam with Veno-Arterial Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Severe Renal Impairment: A Case Report.Infection and drug resistance · 2026Article
- Piperacillin/tazobactam clearance predicted by non-creatinine based estimates of GFR in critically ill adults.International journal of antimicrobial agents · 2025Article
- Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment.Scientific reports · 2025Article
- Optimizing Drug Therapy in ECMO-Supported Critically Ill Adults: A Narrative Review and Clinical Guide.Pharmacy (Basel, Switzerland) · 2025Review
- Infection and antibiotic patterns in critically ill patients on extracorporeal membrane oxygenation.Turk gogus kalp damar cerrahisi dergisi · 2025Article
- Optimising Meropenem and Piperacillin Dosing in Patients Undergoing Extracorporeal Membrane Oxygenation Without Renal Dysfunction (MEPIMEX).Antibiotics (Basel, Switzerland) · 2025Article
- Pharmacokinetic/Pharmacodynamic of ceftolozane/tazobactam in critically ill patients receiving extracorporeal membrane oxygenation (ECMO): a retrospective cohort analysis.Critical care (London, England) · 2025Article
- Pharmacokinetics of Isavuconazole During Extracorporeal Membrane Oxygenation Support in Critically Ill Patients: A Case Series.Antibiotics (Basel, Switzerland) · 2025Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
24 authors at 12 institutions in 5 countries.
Kiran ShekarAdult Intensive Care Services and Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.
Mohd H Abdul-AzizUniversity of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Vesa ChengUniversity of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Fay BurrowsDepartment of Pharmacy and.
Hergen BuscherDepartment of Intensive Care Medicine, St Vincent's Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-4531-6151
Young-Jae ChoDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.ORCID 0000-0001-6943-4462
Amanda CorleyAdult Intensive Care Services and Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.
Arne DiehlDepartment of Intensive Care and Hyperbaric Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.
Eileen GilderExperiential Development and Graduate Education and Centre for Medicines Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
Stephan M JakobCardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.
Hyung-Sook KimDepartment of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Bianca J LevkovichDepartment of Pharmacy, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Sung Yoon LimDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Shay McGuinnessSchool of Nursing, The University of Auckland, Auckland, New Zealand.
Rachael ParkeDepartment of Intensive Care Medicine and Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; and.
Vincent PellegrinoDepartment of Intensive Care and Hyperbaric Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.
Yok-Ai QueCardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.
Claire ReynoldsDepartment of Intensive Care Medicine, St Vincent's Hospital, Sydney, New South Wales, Australia.
Sam RudhamDepartment of Intensive Care Medicine, St Vincent's Hospital, Sydney, New South Wales, Australia.
Steven C WallisUniversity of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Susan A WelchDepartment of Pharmacy and.
David ZachariasCardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.
John F FraserAdult Intensive Care Services and Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.
Jason A RobertsUniversity of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0001-6218-435X
The University of Queensland · AUAuckland City Hospital · NZSeoul National University Bundang Hospital · KRBond University · AUSt Vincent's Hospital Sydney · AUThe Alfred Hospital · AUGriffith University · AUMonash University · AUUniversité de Montpellier · FRUniversity of Auckland · NZUniversity of Bern · CHUNSW Sydney · AU
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Anti-Infective AgentsExtracorporeal Membrane OxygenationAdultAnti-Bacterial AgentsAustraliaCritical IllnessFemaleHumansMaleMiddle AgedProspective StudiesAnti-Bacterial AgentsAnti-Infective Agentsantifungalsantiviralscritical illnesspharmacokineticsrenal replacement therapy
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT07032987ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.